the invention can be utilized to treat such cancers as carcinomas, sarcomas, lymphomas, Hodgekin's disease, melanomas, mesotheliomas, Burkitt' s lymphoma, the cancer cell population can include, but is not limited to, oral, thyroid, endocrine, skin, gastric, esophageal, laryngeal, pancreatic, colon, bladder, bone, ovarian, cervical, uterine, breast, testicular, prostate, rectal, kidney, liver, and lung cancers
Toxicology assessment of red blood cell The toxicity of AgNPs was determined using hemolytic assessment is very essential for human welfare oriented clinical applications due to its efficient drug delivering capacity
Fiorentino, G
Di W, Zhang Y, Zhang X, Han L, Zhao L, Hao Y, et al